GRK2 and cancer: In the regulation of cancer, GRK2 accumulates in the presence of DNA-damaging agents (e.g., adriamycin) that activate cell cycle arrest, helping to counteract the stimulation of the p53 pathway induced by the G2/M checkpoint mechanism and preventing the apoptosis of blocked cells [94].